Michael Geffner, Chief Medical Officer at Immunovant, Inc. (IMVT), sold 6,522 shares at $28.90 ($188K) on 2024-04-24, disclosed to the SEC on 2024-04-26.
Open-market sale of $188k IMVT by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $28.90 | 3,261 | $94K | 50.0% |
| 2 | $28.90 | 3,261 | $94K | 50.0% |
| Total | $28.90 avg | 6,522 | $188K | 100% |
| Filing → |
| IMVT | SELL | 2025-07-25 | $43K | — | Filing → |
| IMVT | SELL | 2025-07-11 | $20K | — | Filing → |
| IMVT | SELL | 2025-04-25 | $35K | — | Filing → |